文献速递传染病防控与疫情报告免疫规划

罗马尼亚2004年引入MMR疫苗后麻疹特征:聚焦2016至2019年暴发的实验室数据

Characterisation of measles after the introduction of the combined measles-mumps-rubella (MMR) vaccine in 2004 with focus on the laboratory data, 2016 to 2019 outbreak, Romania.
PubMed 文献 · Euro Surveill · 2019-01-01

研究分析了罗马尼亚引入MMR疫苗后的麻疹发病与死亡,并回顾性研究连续三次暴发的血清学和分子数据。当前暴发报告17,533例麻疹病例,93%未接种疫苗,基因型B3为主(n=269),提示多次病毒输入。结论认为当前暴发是疫苗覆盖率不足所致,需提高接种率和监测性能。

要点

  • 当前暴发报告17,533例麻疹病例,其中93%未接种疫苗。
  • 基因型B3为主(n=269),发现多个不同B3基因型提示多次病毒输入。
  • 控制措施包括将首剂MMR接种年龄提前至9-11个月和补种。

核心结论

  • 当前麻疹暴发是疫苗覆盖率不足的结果,需更多措施提高常规MMR接种率和监测性能。

研究设计与样本

  • 分析引入MMR疫苗后的麻疹发病率和死亡率,并回顾性研究三次连续暴发的血清学和分子数据,聚焦当前暴发。

主要发现

  • 当前暴发向国家监测系统报告17,533例麻疹病例,93%未接种疫苗。
  • 从429份样本中分离出麻疹病毒,283份进行了基因分型,基因型B3为主(n=269),偶见D8基因型相关散发病例(n=9)。
  • 前两次暴发中鉴定出基因型D4和D8,检测到多个不同的B3基因型提示多次病毒输入罗马尼亚。

临床怎么用

  • 实施控制措施以提高MMR疫苗接种率,包括将第一剂MMR接种年龄提前至9-11个月,并为未按推荐程序接种的儿童提供补种。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BackgroundSince January 2016, a resurgence of measles in Romania has led to the third measles epidemic in the past 12 years; 64 deaths have been confirmed so far-the highest number of measles-related deaths since the measles-mumps-rubella (MMR) vaccine was introduced in 2004.AimTo provide an overview on the characterisation on measles in Romania after the introduction of the MMR vaccine with focus on the current outbreak, laboratory and molecular analysis.MethodsWe performed an analysis of measles incidence and mortality after the introduction of MMR vaccination and a retrospective study using serological and molecular data in three consecutive outbreaks with focus on the current outbreak.ResultsIn the current outbreak, 17,533 measles cases were notified to the national surveillance system, 93% were unvaccinated. Measles virus was isolated from 429 samples and 283 were genotyped. Genotype B3 was predominant (n = 269) and sporadic measles cases associated with D8 genotype (n = 9) were also observed; genotype D4 and D8 were identified in the previous two measles outbreaks. The detection of several distinct measles virus B3 genotypes suggests multiple virus importations to Romania.ConclusionThe current outbreak is a consequence of insufficient vaccine coverage. Control measures were implemented to improve uptake of MMR vaccine, including administering the first MMR dose at a younger age (9-11 months) and offering catch-up vaccination to children that have not followed the recommended dosing schedule. More measures are needed to improve the surveillance performance and to achieve high routine MMR vaccination coverage.

来源:Euro Surveill,查看原文。版权归原作者所有。

引用

  1. Lazar M, Stănescu A, Penedos AR, et al. Characterisation of measles after the introduction of the combined measles-mumps-rubella (MMR) vaccine in 2004 with focus on the laboratory data, 2016 to 2019 outbreak, Romania. Euro Surveill. 2019. PMID: 31339098. doi:10.2807/1560-7917.ES.2019.24.29.1900041

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。